Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Stroke

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 97 articles:
HTML format
Text format



Single Articles


    May 2018
  1. YAO X, Gersh BJ, Holmes DR Jr, Melduni RM, et al
    Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery.
    JAMA. 2018;319:2116-2126.
    PubMed     Text format     Abstract available


  2. ABBASI J
    Another Nail in the Coffin for Fish Oil Supplements.
    JAMA. 2018;319:1851-1852.
    PubMed     Text format    


    February 2018
  3. CHANG SH, Wen MS, Kuo CF
    Drug Interactions With Non-Vitamin K Oral Anticoagulants-Reply.
    JAMA. 2018;319:830-831.
    PubMed     Text format    


  4. WANG N, Giblin E, Rodgers JE
    Drug Interactions With Non-Vitamin K Oral Anticoagulants.
    JAMA. 2018;319:830.
    PubMed     Text format    


  5. SENNESAEL AL, Henrard S, Spinewine A
    Drug Interactions With Non-Vitamin K Oral Anticoagulants.
    JAMA. 2018;319:829.
    PubMed     Text format    


  6. VAZQUEZ SR, Allen A
    Drug Interactions With Non-Vitamin K Oral Anticoagulants.
    JAMA. 2018;319:829-830.
    PubMed     Text format    


  7. LINNEBUR SA, Hanlon JT
    Drug Interactions With Non-Vitamin K Oral Anticoagulants.
    JAMA. 2018;319:828-829.
    PubMed     Text format    


  8. LI Y, Dong S, Soria-Saucedo R
    Drug Interactions With Non-Vitamin K Oral Anticoagulants.
    JAMA. 2018;319:827-828.
    PubMed     Text format    


  9. GITTLER M, Davis AM
    Guidelines for Adult Stroke Rehabilitation and Recovery.
    JAMA. 2018;319:820-821.
    PubMed     Text format    


  10. ROFFE C, Sim J, Gray R
    Prophylactic Low-Dose Oxygen for Patients With Acute Stroke-Reply.
    JAMA. 2018;319:502.
    PubMed     Text format    


  11. SABER H, Moein HR, Rajamani K
    Prophylactic Low-Dose Oxygen for Patients With Acute Stroke.
    JAMA. 2018;319:501-502.
    PubMed     Text format    


  12. KASNER SE, Messe SR
    Is Patent Foramen Ovale a Risk Factor for Perioperative Stroke?
    JAMA. 2018;319:446-447.
    PubMed     Text format    


  13. NG PY, Ng AK, Subramaniam B, Burns SM, et al
    Association of Preoperatively Diagnosed Patent Foramen Ovale With Perioperative Ischemic Stroke.
    JAMA. 2018;319:452-462.
    PubMed     Text format     Abstract available


    January 2018
  14. FERRARIS VA
    Left Atrial Appendage Occlusion During Cardiac Operations for Prevention of Thromboembolic Events.
    JAMA. 2018;319:345-347.
    PubMed     Text format    


    September 2017
  15. ROFFE C, Nevatte T, Sim J, Bishop J, et al
    Effect of Routine Low-Dose Oxygen Supplementation on Death and Disability in Adults With Acute Stroke: The Stroke Oxygen Study Randomized Clinical Trial.
    JAMA. 2017;318:1125-1135.
    PubMed     Text format     Abstract available


  16. LICHTMAN JH, Jones MR, Leifheit EC, Sheffet AJ, et al
    Carotid Endarterectomy and Carotid Artery Stenting in the US Medicare Population, 1999-2014.
    JAMA. 2017;318:1035-1046.
    PubMed     Text format     Abstract available


    August 2017
  17. MACK MJ, Acker MA, Gelijns AC, Overbey JR, et al
    Effect of Cerebral Embolic Protection Devices on CNS Infarction in Surgical Aortic Valve Replacement: A Randomized Clinical Trial.
    JAMA. 2017;318:536-547.
    PubMed     Text format     Abstract available


  18. LAPERGUE B, Blanc R, Gory B, Labreuche J, et al
    Effect of Endovascular Contact Aspiration vs Stent Retriever on Revascularization in Patients With Acute Ischemic Stroke and Large Vessel Occlusion: The ASTER Randomized Clinical Trial.
    JAMA. 2017;318:443-452.
    PubMed     Text format     Abstract available


    July 2017
  19. LAU WCY, Wong ICK, Chan EW
    Osteoporotic Fractures Associated With Dabigatran vs Warfarin-Reply.
    JAMA. 2017;318:91.
    PubMed     Text format    


  20. SUGIYAMA T
    Osteoporotic Fractures Associated With Dabigatran vs Warfarin.
    JAMA. 2017;318:90-91.
    PubMed     Text format    


    May 2017
  21. ROTH GA, Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs RW, et al
    Trends and Patterns of Geographic Variation in Cardiovascular Mortality Among US Counties, 1980-2014.
    JAMA. 2017;317:1976-1992.
    PubMed     Text format     Abstract available


    March 2017
  22. BOSEL J, Schoneberger S
    Sedation vs Intubation for Patients With Acute Stroke Undergoing Thrombectomy-Reply.
    JAMA. 2017;317:1177-1178.
    PubMed     Text format    


  23. SAVER JL, Goyal M, Hill MD
    Time to Endovascular Thrombectomy for Acute Stroke-Reply.
    JAMA. 2017;317:1175-1176.
    PubMed     Text format    


  24. SEE AP, Ducruet AF
    Sedation vs Intubation for Patients With Acute Stroke Undergoing Thrombectomy.
    JAMA. 2017;317:1176-1177.
    PubMed     Text format    


  25. BUERKLE H, Goebel U
    Sedation vs Intubation for Patients With Acute Stroke Undergoing Thrombectomy.
    JAMA. 2017;317:1177.
    PubMed     Text format    


  26. KANSAGRA AP
    Time to Endovascular Thrombectomy for Acute Stroke.
    JAMA. 2017;317:1175.
    PubMed     Text format    


  27. LAU WC, Chan EW, Cheung CL, Sing CW, et al
    Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation.
    JAMA. 2017;317:1151-1158.
    PubMed     Text format     Abstract available


  28. POTPARA TS, Lip GY
    Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation.
    JAMA. 2017;317:1115-1116.
    PubMed     Text format    


  29. XIAN Y, O'Brien EC, Liang L, Xu H, et al
    Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation.
    JAMA. 2017;317:1057-1067.
    PubMed     Text format     Abstract available


  30. MICHA R, Penalvo JL, Cudhea F, Imamura F, et al
    Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States.
    JAMA. 2017;317:912-924.
    PubMed     Text format     Abstract available


    February 2017
  31. BILECEN S, de Groot JA, Kalkman CJ, Spanjersberg AJ, et al
    Effect of Fibrinogen Concentrate on Intraoperative Blood Loss Among Patients With Intraoperative Bleeding During High-Risk Cardiac Surgery: A Randomized Clinical Trial.
    JAMA. 2017;317:738-747.
    PubMed     Text format     Abstract available


    January 2017
  32. BRAGG F, Holmes MV, Iona A, Guo Y, et al
    Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China.
    JAMA. 2017;317:280-289.
    PubMed     Text format     Abstract available


  33. FOROUZANFAR MH, Liu P, Roth GA, Ng M, et al
    Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015.
    JAMA. 2017;317:165-182.
    PubMed     Text format     Abstract available


    December 2016
  34. MUTH CC
    Recovery After Stroke.
    JAMA. 2016;316:2440.
    PubMed     Text format    


    November 2016
  35. KAVOUSI M, Desai CS, Ayers C, Blumenthal RS, et al
    Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women: A Meta-analysis.
    JAMA. 2016 Nov 15. doi: 10.1001/jama.2016.17020.
    PubMed     Text format     Abstract available


  36. KARAYIANNIS C, Phan TG, Srikanth V
    Intensive vs Standard Blood Pressure Control for Older Adults.
    JAMA. 2016;316:1920-1921.
    PubMed     Text format    


    October 2016
  37. SCHONENBERGER S, Uhlmann L, Hacke W, Schieber S, et al
    Effect of Conscious Sedation vs General Anesthesia on Early Neurological Improvement Among Patients With Ischemic Stroke Undergoing Endovascular Thrombectomy: A Randomized Clinical Trial.
    JAMA. 2016 Oct 26. doi: 10.1001/jama.2016.16623.
    PubMed     Text format     Abstract available


    September 2016
  38. SAVER JL, Goyal M, van der Lugt A, Menon BK, et al
    Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis.
    JAMA. 2016;316:1279-88.
    PubMed     Text format     Abstract available


  39. WARACH S, Johnston SC
    Endovascular Thrombectomy for Ischemic Stroke: The Second Quantum Leap in Stroke Systems of Care?
    JAMA. 2016;316:1265-6.
    PubMed     Text format    


  40. SILVERMAN MG, Ference BA, Im K, Wiviott SD, et al
    Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.
    JAMA. 2016;316:1289-97.
    PubMed     Text format     Abstract available


    August 2016
  41. STEIGER N, Cifu AS
    Primary Prevention of Stroke.
    JAMA. 2016;316:658-9.
    PubMed     Text format    


  42. LIVINGSTON EH
    JAMA PATIENT PAGE. Screening for Lipid Disorders in Children and Adolescents.
    JAMA. 2016;316:678.
    PubMed     Text format    


  43. POKORNEY SD, Simon DN, Thomas L, Gersh BJ, et al
    Stability of International Normalized Ratios in Patients Taking Long-term Warfarin Therapy.
    JAMA. 2016;316:661-3.
    PubMed     Text format    


  44. LOZANO P, Henrikson NB, Dunn J, Morrison CC, et al
    Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2016;316:645-55.
    PubMed     Text format     Abstract available


  45. LOZANO P, Henrikson NB, Morrison CC, Dunn J, et al
    Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2016;316:634-44.
    PubMed     Text format     Abstract available


  46. FRIEDEN TR
    Sodium Reduction--Saving Lives by Putting Choice Into Consumers' Hands.
    JAMA. 2016;316:579-80.
    PubMed     Text format    


    July 2016
  47. WINSTEIN C, Wolf S, Dromerick AW
    Task-Oriented Rehabilitation Program for Stroke--Reply.
    JAMA. 2016;316:102.
    PubMed     Text format    


  48. PETERS HT, Page SJ
    Task-Oriented Rehabilitation Program for Stroke.
    JAMA. 2016;316:101-2.
    PubMed     Text format    


    June 2016
  49. WANG Y, Zhao X, Lin J, Li H, et al
    Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack.
    JAMA. 2016 Jun 23. doi: 10.1001/jama.2016.8662.
    PubMed     Text format     Abstract available


  50. GANZ P, Heidecker B, Hveem K, Jonasson C, et al
    Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease.
    JAMA. 2016;315:2532-41.
    PubMed     Text format     Abstract available


  51. MANSON JE, Shufelt CL, Robins JM
    The Potential for Postrandomization Confounding in Randomized Clinical Trials.
    JAMA. 2016;315:2273-4.
    PubMed     Text format    


    May 2016
  52. MILLS KT, Chen J, Yang W, Appel LJ, et al
    Sodium Excretion and the Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease.
    JAMA. 2016;315:2200-10.
    PubMed     Text format     Abstract available


  53. POWE NR, Bibbins-Domingo K
    Dietary Salt, Kidney Disease, and Cardiovascular Health.
    JAMA. 2016;315:2173-4.
    PubMed     Text format    


    April 2016
  54. BADHIWALA JH, Nassiri F, Almenawer SA
    Mechanical Thrombectomy and Functional Outcomes After Stroke--Reply.
    JAMA. 2016;315:1792-3.
    PubMed     Text format    


  55. RODRIGUES FB, Langhorne P, Costa J
    Mechanical Thrombectomy and Functional Outcomes After Stroke.
    JAMA. 2016;315:1791-2.
    PubMed     Text format    


  56. ELGENDY IY, Bhatt DL, Bavry AA
    Mechanical Thrombectomy and Functional Outcomes After Stroke.
    JAMA. 2016;315:1791.
    PubMed     Text format    


    March 2016
  57. ROUGH K, Bateman BT, Patorno E, Desai RJ, et al
    Suppression of Substance Abuse Claims in Medicaid Data and Rates of Diagnoses for Non-Substance Abuse Conditions.
    JAMA. 2016;315:1164-6.
    PubMed     Text format    


    February 2016
  58. WINSTEIN CJ, Wolf SL, Dromerick AW, Lane CJ, et al
    Effect of a Task-Oriented Rehabilitation Program on Upper Extremity Recovery Following Motor Stroke: The ICARE Randomized Clinical Trial.
    JAMA. 2016;315:571-81.
    PubMed     Text format     Abstract available


    January 2016
  59. JACOB JA
    Greater Health Care Spending May Moderate Recession's Negative Health Effects.
    JAMA. 2016;315:237-9.
    PubMed     Text format    


    December 2015
  60. CEJAS DM
    A PIECE OF MY MIND. Every Little Anniversary.
    JAMA. 2015;314:2237.
    PubMed     Text format    


    November 2015
  61. BEN FREEDMAN S, Lowres N
    Asymptomatic Atrial Fibrillation: The Case for Screening to Prevent Stroke.
    JAMA. 2015;314:1911-2.
    PubMed     Text format    


  62. BADHIWALA JH, Nassiri F, Alhazzani W, Selim MH, et al
    Endovascular Thrombectomy for Acute Ischemic Stroke: A Meta-analysis.
    JAMA. 2015;314:1832-43.
    PubMed     Text format     Abstract available


  63. WARDLAW JM, Dennis MS
    Thrombectomy for Acute Ischemic Stroke.
    JAMA. 2015;314:1803-5.
    PubMed     Text format    


    October 2015
  64. MA J, Ward EM, Siegel RL, Jemal A, et al
    Temporal Trends in Mortality in the United States, 1969-2013.
    JAMA. 2015;314:1731-9.
    PubMed     Text format     Abstract available


  65. BUCHHOLZ L
    Working Late, Courting Stroke.
    JAMA. 2015 Oct 9:1-2. doi: 10.1001/jama.2015.12245.
    PubMed     Text format    


    September 2015
  66. JIN J
    JAMA PATIENT PAGE. Nonsteroidal Anti-inflammatory Drugs.
    JAMA. 2015;314:1084.
    PubMed     Text format    


  67. PENCINA MJ, D'Agostino RB Sr
    Evaluating Discrimination of Risk Prediction Models: The C Statistic.
    JAMA. 2015;314:1063-4.
    PubMed     Text format    


  68. LIP GY, Lane DA
    Assessing Eligibility for Anticoagulation After Diagnosis of Atrial Fibrillation--Reply.
    JAMA. 2015;314:949-50.
    PubMed     Text format    


  69. MARIETTA M, Formoso G, Marata AM
    Assessing Eligibility for Anticoagulation After Diagnosis of Atrial Fibrillation.
    JAMA. 2015;314:949.
    PubMed     Text format    


    August 2015
  70. MELGAARD L, Gorst-Rasmussen A, Lane DA, Rasmussen LH, et al
    Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    JAMA. 2015 Aug 30:1-9. doi: 10.1001/jama.2015.10725.
    PubMed     Text format     Abstract available


  71. PRABHAKARAN S, Ruff I, Bernstein RA
    Intervention for Acute Stroke--Reply.
    JAMA. 2015;314:626-7.
    PubMed     Text format    


  72. ALPER BS, Malone-Moses M, Prasad K
    Intervention for Acute Stroke.
    JAMA. 2015;314:625-6.
    PubMed     Text format    


    July 2015
  73. BERIAN JR, Livingston EH
    JAMA PATIENT PAGE. Preventing Stroke in People With Atrial Fibrillation.
    JAMA. 2015;314:310.
    PubMed     Text format    


  74. MOSS JD, Cifu AS
    Management of Anticoagulation in Patients With Atrial Fibrillation.
    JAMA. 2015;314:291-2.
    PubMed     Text format    


  75. PRYSTOWSKY EN, Padanilam BJ, Fogel RI
    Treatment of Atrial Fibrillation.
    JAMA. 2015;314:278-88.
    PubMed     Text format     Abstract available


  76. DI ANGELANTONIO E, Kaptoge S, Wormser D, Willeit P, et al
    Association of Cardiometabolic Multimorbidity With Mortality.
    JAMA. 2015;314:52-60.
    PubMed     Text format     Abstract available


  77. LEVINE DA, Galecki AT, Langa KM, Unverzagt FW, et al
    Trajectory of Cognitive Decline After Incident Stroke.
    JAMA. 2015;314:41-51.
    PubMed     Text format     Abstract available


  78. GORELICK PB, Nyenhuis D
    Stroke and Cognitive Decline.
    JAMA. 2015;314:29-30.
    PubMed     Text format    


    May 2015
  79. LIP GY, Lane DA
    Stroke prevention in atrial fibrillation: a systematic review.
    JAMA. 2015;313:1950-62.
    PubMed     Text format     Abstract available


  80. BAUCHNER H, Fontanarosa PB
    Expression of Concern: Sato et al. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA. 2005;293(9):1082-1088.
    JAMA. 2015;313:1914.
    PubMed     Text format    


    April 2015
  81. PRABHAKARAN S, Ruff I, Bernstein RA
    Acute stroke intervention: a systematic review.
    JAMA. 2015;313:1451-62.
    PubMed     Text format     Abstract available


  82. CHIKWE J, Chiang YP, Egorova NN, Itagaki S, et al
    Survival and outcomes following bioprosthetic vs mechanical mitral valve replacement in patients aged 50 to 69 years.
    JAMA. 2015;313:1435-42.
    PubMed     Text format     Abstract available


    March 2015
  83. ZAIDAT OO, Fitzsimmons BF, Woodward BK, Wang Z, et al
    Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial.
    JAMA. 2015;313:1240-8.
    PubMed     Text format     Abstract available


  84. CHIMOWITZ MI, Derdeyn CP
    Endovascular therapy for atherosclerotic intracranial arterial stenosis: back to the drawing board.
    JAMA. 2015;313:1219-20.
    PubMed     Text format    


  85. HUO Y, Li J, Qin X, Huang Y, et al
    Efficacy of Folic Acid Therapy in Primary Prevention of Stroke Among Adults With Hypertension in China: The CSPPT Randomized Clinical Trial.
    JAMA. 2015 Mar 15. doi: 10.1001/jama.2015.2274.
    PubMed     Text format     Abstract available


  86. STAMPFER M, Willett W
    Folate Supplements for Stroke Prevention: Targeted Trial Trumps the Rest.
    JAMA. 2015 Mar 15. doi: 10.1001/jama.2015.1961.
    PubMed     Text format    


  87. REDDY VY, Holmes D
    Left atrial appendage closure for atrial fibrillation--reply.
    JAMA. 2015;313:1057-8.
    PubMed     Text format    


  88. STOLLBERGER C, Schneider B
    Left atrial appendage closure for atrial fibrillation.
    JAMA. 2015;313:1057.
    PubMed     Text format    


  89. HOLMES DR JR, Brennan JM, Rumsfeld JS, Dai D, et al
    Clinical outcomes at 1 year following transcatheter aortic valve replacement.
    JAMA. 2015;313:1019-28.
    PubMed     Text format     Abstract available


    February 2015
  90. KURAMATSU JB, Gerner ST, Schellinger PD, Glahn J, et al
    Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.
    JAMA. 2015;313:824-36.
    PubMed     Text format     Abstract available


  91. SCHJERNING OLSEN AM, Gislason GH, McGettigan P, Fosbol E, et al
    Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.
    JAMA. 2015;313:805-14.
    PubMed     Text format     Abstract available


    January 2015
  92. WEYER GW, Davis AM
    Screening for asymptomatic carotid artery stenosis.
    JAMA. 2015;313:192-3.
    PubMed     Text format    


    December 2014
  93. GIALDINI G, Bhave PD, Kamel H
    Stroke risk following perioperative atrial fibrillation--reply.
    JAMA. 2014;312:2410-1.
    PubMed     Text format    


  94. TRICOCI P
    Stroke risk following perioperative atrial fibrillation.
    JAMA. 2014;312:2410.
    PubMed     Text format    


  95. KURLANSKY P
    Stroke risk following perioperative atrial fibrillation.
    JAMA. 2014;312:2410.
    PubMed     Text format    


  96. PATEL MS, Volpp KG, Small DS, Hill AS, et al
    Association of the 2011 ACGME resident duty hour reforms with mortality and readmissions among hospitalized Medicare patients.
    JAMA. 2014;312:2364-73.
    PubMed     Text format     Abstract available


  97. RUBIN R
    Stroke care projected to add up to more than previously thought.
    JAMA. 2014;312:2198-200.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: